Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
vaccine development
Pharma
Emergent lines up BARDA pact to supply anthrax shot in the US
The U.S.' BARDA is laying out $75 million to exercise an option for additional doses of Emergent’s two-dose anthrax shot Cyfendus.
Fraiser Kansteiner
Nov 28, 2023 4:20pm
Daiichi Sankyo secures COVID vaccine supply pact in Japan
Nov 17, 2023 9:45am
Micron snags big Gates grant to produce needle-free vaccines
Nov 16, 2023 12:53pm
Capturing COVID: Biopharma through the lens during the pandemic
Nov 13, 2023 7:45am
Pfizer takes $5.6B in Paxlovid, Comirnaty inventory write-offs
Oct 31, 2023 10:12am
Pfizer beats out GSK with nod for first 5-in-1 meningitis shot
Oct 20, 2023 3:50pm
